481 related articles for article (PubMed ID: 16962229)
1. The mysterious trace amines: protean neuromodulators of synaptic transmission in mammalian brain.
Burchett SA; Hicks TP
Prog Neurobiol; 2006 Aug; 79(5-6):223-46. PubMed ID: 16962229
[TBL] [Abstract][Full Text] [Related]
2. Mammalian central nervous system trace amines. Pharmacologic amphetamines, physiologic neuromodulators.
Berry MD
J Neurochem; 2004 Jul; 90(2):257-71. PubMed ID: 15228583
[TBL] [Abstract][Full Text] [Related]
3. Trace amines: identification of a family of mammalian G protein-coupled receptors.
Borowsky B; Adham N; Jones KA; Raddatz R; Artymyshyn R; Ogozalek KL; Durkin MM; Lakhlani PP; Bonini JA; Pathirana S; Boyle N; Pu X; Kouranova E; Lichtblau H; Ochoa FY; Branchek TA; Gerald C
Proc Natl Acad Sci U S A; 2001 Jul; 98(16):8966-71. PubMed ID: 11459929
[TBL] [Abstract][Full Text] [Related]
4. The potential of trace amines and their receptors for treating neurological and psychiatric diseases.
Berry MD
Rev Recent Clin Trials; 2007 Jan; 2(1):3-19. PubMed ID: 18473983
[TBL] [Abstract][Full Text] [Related]
5. Biochemical plasticity of synaptic transmission: a critical review of Dale's Principle.
Sabelli HC; Mosnaim AD; Vazquez AJ; Giardina WJ; Borison RL; Pedemonte WA
Biol Psychiatry; 1976 Aug; 11(4):481-524. PubMed ID: 9160
[TBL] [Abstract][Full Text] [Related]
6. Amphetamine, 3,4-methylenedioxymethamphetamine, lysergic acid diethylamide, and metabolites of the catecholamine neurotransmitters are agonists of a rat trace amine receptor.
Bunzow JR; Sonders MS; Arttamangkul S; Harrison LM; Zhang G; Quigley DI; Darland T; Suchland KL; Pasumamula S; Kennedy JL; Olson SB; Magenis RE; Amara SG; Grandy DK
Mol Pharmacol; 2001 Dec; 60(6):1181-8. PubMed ID: 11723224
[TBL] [Abstract][Full Text] [Related]
7. The vascular effects of trace amines and amphetamines.
Broadley KJ
Pharmacol Ther; 2010 Mar; 125(3):363-75. PubMed ID: 19948186
[TBL] [Abstract][Full Text] [Related]
8. Molecular and pharmacological properties of insect biogenic amine receptors: lessons from Drosophila melanogaster and Apis mellifera.
Blenau W; Baumann A
Arch Insect Biochem Physiol; 2001 Sep; 48(1):13-38. PubMed ID: 11519073
[TBL] [Abstract][Full Text] [Related]
9. Inhibitory effects of trace amines on rat midbrain dopaminergic neurons.
Geracitano R; Federici M; Prisco S; Bernardi G; Mercuri NB
Neuropharmacology; 2004 May; 46(6):807-14. PubMed ID: 15033340
[TBL] [Abstract][Full Text] [Related]
10. The emerging roles of human trace amines and human trace amine-associated receptors (hTAARs) in central nervous system.
Khan MZ; Nawaz W
Biomed Pharmacother; 2016 Oct; 83():439-449. PubMed ID: 27424325
[TBL] [Abstract][Full Text] [Related]
11. Trace amines differentially regulate adult locomotor activity, cocaine sensitivity, and female fertility in Drosophila melanogaster.
Hardie SL; Zhang JX; Hirsh J
Dev Neurobiol; 2007 Sep; 67(10):1396-405. PubMed ID: 17638385
[TBL] [Abstract][Full Text] [Related]
12. 5-HT receptor regulation of neurotransmitter release.
Fink KB; Göthert M
Pharmacol Rev; 2007 Dec; 59(4):360-417. PubMed ID: 18160701
[TBL] [Abstract][Full Text] [Related]
13. Neurotransmitter transporters in schistosomes: structure, function and prospects for drug discovery.
Ribeiro P; Patocka N
Parasitol Int; 2013 Dec; 62(6):629-38. PubMed ID: 23800409
[TBL] [Abstract][Full Text] [Related]
14. [beta Phenylethylamine: psychopharmacological and clinical aspects].
Nakagawara M
Yakubutsu Seishin Kodo; 1986 Sep; 6(3):295-307. PubMed ID: 3101312
[TBL] [Abstract][Full Text] [Related]
15. Beta-phenylethylamine alters monoamine transporter function via trace amine-associated receptor 1: implication for modulatory roles of trace amines in brain.
Xie Z; Miller GM
J Pharmacol Exp Ther; 2008 May; 325(2):617-28. PubMed ID: 18182557
[TBL] [Abstract][Full Text] [Related]
16. Stereospecific receptor sites for d-lysergic acid diethylamide in rat brain: effects of neurotransmitters, amine antagonists, and other psychotropic drugs.
Lovell RA; Freedman DX
Mol Pharmacol; 1976 Jul; 12(4):620-30. PubMed ID: 8700
[No Abstract] [Full Text] [Related]
17. Membrane permeability of trace amines: evidence for a regulated, activity-dependent, nonexocytotic, synaptic release.
Berry MD; Shitut MR; Almousa A; Alcorn J; Tomberli B
Synapse; 2013 Oct; 67(10):656-67. PubMed ID: 23564683
[TBL] [Abstract][Full Text] [Related]
18. From the Golgi-Cajal mapping to the transmitter-based characterization of the neuronal networks leading to two modes of brain communication: wiring and volume transmission.
Fuxe K; Dahlström A; Höistad M; Marcellino D; Jansson A; Rivera A; Diaz-Cabiale Z; Jacobsen K; Tinner-Staines B; Hagman B; Leo G; Staines W; Guidolin D; Kehr J; Genedani S; Belluardo N; Agnati LF
Brain Res Rev; 2007 Aug; 55(1):17-54. PubMed ID: 17433836
[TBL] [Abstract][Full Text] [Related]
19. Cardiac effects of trace amines: pharmacological characterization of trace amine-associated receptors.
Frascarelli S; Ghelardoni S; Chiellini G; Vargiu R; Ronca-Testoni S; Scanlan TS; Grandy DK; Zucchi R
Eur J Pharmacol; 2008 Jun; 587(1-3):231-6. PubMed ID: 18486124
[TBL] [Abstract][Full Text] [Related]
20. Endogenous hallucinogens as ligands of the trace amine receptors: a possible role in sensory perception.
Wallach JV
Med Hypotheses; 2009 Jan; 72(1):91-4. PubMed ID: 18805646
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]